...
机译:药物洗脱冠状动脉支架
GREGORY J. DEHMER, MD, and KYLE J. SMITH, MD, Scott & White Healthcare, Temple, TexasThe AuthorsGREGORY J. DEHMER, MD, is a professor in the Department of Medicine at the Texas A&M Health Science Center College of Medicine, College Station, and director of the Cardiology Division at Scott & White Healthcare, Temple, Tex.KYLE J. SMITH, MD, has recently completed an interventional cardiology fellowship at Texas A&M Health Science Center College of Medicine/Scott & White Healthcare.Address correspondence to Gregory J. Dehmer, MD, Scott & White Healthcare, 2401 South 31 St., Temple, TX 76508 (e-mail: gdehmer@swmail.sw.org). Reprints are not available from the authors.Author disclosure: Nothing to disclose.;
机译:左主冠状动脉严重狭窄的女性经皮冠状动脉介入治疗(使用药物洗脱支架)与冠状动脉旁路移植术的比较(来自用于左主冠状动脉疾病登记的女性药物洗脱支架)
机译:在创新和药物洗脱支架(WIN-DES)协作中进行经皮冠状动脉介入药物洗脱支架的女性冠状动脉钙化的相关性和影响
机译:经皮冠状动脉介入治疗无保护的左主冠状动脉的眼部/中轴病变与远端分叉病变的长期临床结果:DELTA Registry(左主冠状动脉疾病药物洗脱支架):评估经皮冠状动脉介入治疗的多中心注册表与冠状动脉搭桥术进行左主治疗
机译:药物洗脱支架在冠状动脉旁路移植物病变治疗中的疗效
机译:使用胺和羧酸烷硫醇自组装单层将纤连蛋白共价连接到316L不锈钢上:冠状动脉支架的应用。
机译:单冠状动脉支架置入术患者9个月血管造影随访结果和可生物降解聚合物药物洗脱支架与第二代耐用聚合物药物洗脱支架的长期临床疗效
机译:TCT-233在未保护的左主干冠状动脉病变且SYNTAX评分≤32的患者中,药物洗脱支架植入与冠状动脉旁路移植术的比较:第二代药物洗脱支架的影响